LivaNova (LIVN) Liabilities from Discontinued Operations (2016 - 2021)
LivaNova (LIVN) reported Liabilities from Discontinued Operations of 27118000.0 for Q1 2021, down 8.63% sequentially from 29679000.0 in Q4 2020.
LivaNova (LIVN) Liabilities from Discontinued Operations (2016 - 2021) Analysis & Trends
LivaNova (LIVN) has 5 years of Liabilities from Discontinued Operations data on file, last reported at 27118000.0 in Q1 2021.
- For the quarter ending Q1 2021, Liabilities from Discontinued Operations changed N/A year-over-year to 27118000.0; the trailing twelve-month figure through Mar 2021 stood at 27118000.0 (changed N/A YoY), and the FY2020 full-year result was 29679000.0, changed N/A from the prior year.
- Liabilities from Discontinued Operations slipped to 27118000.0 in Q1 2021, from 29679000.0 in the prior quarter.
- In the past five years, Liabilities from Discontinued Operations ranged from a high of 84993000.0 in Q1 2018 to a low of 27118000.0 in Q1 2021.
- A 4-year average of 54966250.0 and a median of 53877000.0 in 2017 frame the typical range for Liabilities from Discontinued Operations.
- Peak annual rise in Liabilities from Discontinued Operations reached 6.21% in 2017, while the deepest fall reached 6.21% in 2017.
- Tracing LIVN's Liabilities from Discontinued Operations over 4 years: stood at 78075000.0 in 2017, then gained by 8.86% to 84993000.0 in 2018, then tumbled by 65.08% to 29679000.0 in 2020, then dropped by 8.63% to 27118000.0 in 2021.
- Business Quant data shows LIVN's Liabilities from Discontinued Operations at 27118000.0 in Q1 2021, 29679000.0 in Q4 2020, and 84993000.0 in Q1 2018.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | LivaNova | 4.30 Bn | 3.76 Bn | 243.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2021 | 27.12 Mn |
| Mar 31, 2021 | 27.12 Mn |
| Dec 31, 2020 | 29.68 Mn |
| Dec 31, 2020 | 29.68 Mn |
| Mar 31, 2018 | 84.99 Mn |
| Mar 31, 2018 | 84.99 Mn |
| Dec 31, 2017 | 78.08 Mn |
| Dec 31, 2017 | 78.08 Mn |
| Dec 31, 2016 | 83.24 Mn |
| Dec 31, 2016 | 83.24 Mn |